Michele Medici

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

Giuseppe Toffoli, Erika Cecchin, Giuseppe Corona et al. · Journal of Clinical Oncology · 2006 · 337 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

Rolando Nortilli, Savina Aversa, Adriano Paccagnella et al. · Melanoma Research · 2001 · 83 citations

Medicine, Oncology, Pharmacology +11

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study

Maria Grazia Ghi, Adriano Paccagnella, Paola D'Amanzo et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 40 citations · Full text

Medicine, Oncology, Chemotherapy +14

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Sara Gagno, Mario D’Andrea, Mauro Mansutti et al. · Clinical Breast Cancer · 2018 · 10 citations · Full text

Medicine, Genetics, Oncology +15